金迪克:已上市销售的产品为四价流感病毒裂解疫苗

Core Viewpoint - The company focuses on the research, production, and sales of human vaccines, with a portfolio that includes 10 vaccine products targeting five infectious diseases [2] Group 1: Company Overview - The company has developed vaccines for influenza, rabies, chickenpox, shingles, and pneumonia [2] - Currently, the only product available on the market is the quadrivalent influenza virus split vaccine [2]

JIANGSU GDK-金迪克:已上市销售的产品为四价流感病毒裂解疫苗 - Reportify